PEM — Post-Exertional Malaise

5. PEM — post-exertional malaise

Post-exertional malaise (PEM) is the characteristic core symptom of ME/CFS and a central feature of Long COVID. What is meant is a disproportionate, often time-delayed worsening of symptoms and functioning after an exertion that was tolerated without problems before the illness began. The Bateman Horne Center describes PEM as the defining hallmark symptom that helps to distinguish ME/CFS from other states of exhaustion [2]. (A note on precision: the term "pathognomonic", sometimes used, is strictly speaking too strong. PEM is the most strongly distinguishing feature, but it does not occur in absolutely all those affected and is not in every case exclusive to ME/CFS. As "highly specific/leading" the statement holds; as "proving in the narrow sense" it does not.) According to the NICE guideline NG206 (2021), PEM is defined by three features: the onset is often delayed by hours or days, the reaction is disproportionate to the activity, and recovery is prolonged — hours, days, weeks or longer. There PEM is one of four core symptoms required for the diagnosis (alongside disabling fatigue, unrefreshing sleep and cognitive disturbances) [1].

Triggers and course

PEM can be triggered by very different stimuli. Besides physical exertion (even sitting, brushing teeth, showering, cooking, walking), this includes cognitive demands (reading, writing, screen use, concentration), emotional stress (excitement, anger, grief), orthostatic load (long standing, upright posture, heat) and sensory stimuli (noise, bright light, strong smells) [2]. Characteristic is the delayed latency: the worsening often does not set in immediately but typically with a delay of hours to 1–2 days (often in the range of 12–48 hours); its peak may only be reached after about 24–72 hours — unlike normal tiredness, which sets in immediately and subsides quickly with rest [3][4]. The duration ranges from hours through days and weeks to months in severely affected people, with the severity often out of all proportion to the trigger [1][4]. The symptom spectrum includes flu-like complaints (sore throat, swollen lymph nodes, feeling feverish), increased fatigue, cognitive dysfunction ("brain fog"), muscle and joint pain, headaches, unrefreshing sleep, sensory hypersensitivity and orthostatic intolerance [4]. The Open Medicine Foundation describes PEM fatigue as fundamentally different from normal tiredness — "as if every muscle were leaden". Affected people report PEM markedly more often than people without ME/CFS — this clear difference is one of the reasons PEM is regarded as a core diagnostic criterion (see NICE NG206 above) [1][4].

Push-crash cycle and pacing

A common pattern is the push-crash cycle: on "good days" people overactivate to catch up, which triggers a delayed relapse ("crash"). Prevention is through pacing — deliberately budgeting one's strength and staying within one's individual "energy envelope", i.e. below the personal exertion limit at which no worsening occurs [3]. Pacing is not a cure but a strategy for symptom control and for avoiding worsening.

Important safety note: a graded physical activation increased according to a fixed plan (graded exercise therapy, GET) is not to be equated with pacing in ME/CFS. The NICE guideline NG206 (2021) explicitly no longer recommends rigid GET escalation programmes, because they can trigger PEM and worsen the condition [1]. Activity should therefore remain adapted to exertion and symptom-guided, not following a prescribed escalation scheme.

Making it objective: 2-day CPET

One approach to making the abnormal exertion intolerance measurable is the 2-day CPET: two maximal cardiopulmonary exercise tests 24 hours apart. People with ME/CFS typically show reduced performance on day 2, while healthy people remain largely stable — discussed by the National Academy of Medicine (2015, IOM report) as a possible objective expression of PEM [8]. A study in the Journal of Translational Medicine (2024, n=55) found on day 2 a drop in VO2peak of about 6 % (p≤0.01) and in VO2 at the ventilatory threshold (VT1/VAT) of about 6.7 % (p≤0.05), while controls stayed unchanged [5]. Historically the reported values range more widely — VO2peak drop roughly between −5 % and −22 %, at the ventilatory threshold roughly −6 % to −27 % [6]. The VT1 (aerobic/ventilatory threshold, depending on fitness roughly in the range of 40–75 % of VO2max, determined e.g. by the V-slope method) is discussed as a particularly disease-relevant finding and serves in some pacing concepts as an individual heart-rate limit [6]. (Assessment: the exact percentage values and the label as the "most disease-specific finding" come from individual studies and reviews; they are not to be read as normative values established across all cohorts.)

Important is the uncertainty of the data: not all studies reproduce the drop. A study in Frontiers in Physiology (given as: 2026) found no significant change in VO2peak (22.3 vs. 22.5 mL/kg/min) or peak power (127 W on both days) and questioned the suitability of the method for defining PEM — the subjectively perceived exertion, however, was increased [7]. (Verified: Frontiers in Physiology, 2026 — full text; the year and figures match the primary source.) The 2-day CPET remains scientifically disputed and, because of the real risk of triggering a severe, sometimes long-lasting PEM crash in the process, is clinically not routinely recommended; it should at most be considered in specialised settings after careful weighing of benefit and risk.

Capturing it in everyday life: DSQ-PEM

More practical and low-risk is the DSQ-PEM (DePaul Symptom Questionnaire, PEM short form) with five core items — for example a "dead, heavy feeling after starting to exert oneself", "physical exhaustion after minimal exertion" or "mental exhaustion after the slightest effort" — each rated by frequency and severity on a scale of 0–4 [12]. In common evaluations, PEM-positive means that frequency AND severity each reach ≥2; in validation data a very high proportion of ME/CFS patients (reported: ~97 %) affirmed at least one item at least moderately for at least half the time (internal consistency Cronbach's alpha ~0.84). In addition, the questionnaire captures symptom delay, PEM duration, possible triggers and the effectiveness of pacing [12][13]. (Verified against the original study: Cotler, Holtzman, Dudun & Jason, 2018, Diagnostics (MDPI) — full text; the 97 % figure and Cronbach's alpha of 0.84 match the primary source. A figure of "14" triggers asked about, named in the source text, could not be confirmed there and has been removed.)

Note

For PEM there is no approved causal medication and no proven cure. Symptom-oriented measures (e.g. against pain or orthostatic intolerance) are used individually and often off-label; their evidence is limited, and their use and dosing belong in a doctor's hands (possible side effects and interactions). The most important evidence-supported strategy remains avoiding overexertion through pacing; rigid increases in activity (GET) are not recommended [1][3]. In case of persistent or increasing worsening, new or alarming symptoms, medical assessment should be sought. This text serves as information, does not replace medical advice and is not a promise of a cure.